Medicinal Identification of Abacavir Sulfate Sulfate, Abarelix, and Abiraterone Acetate

Wiki Article

These substances, Abacavir Sulfate, Abarelix, and Abiraterone Acetate, each possess different chemical structures leading to their varying pharmacological effects. Abacavir Sulfate, a nucleoside reverse transcriptase inhibitor, is readily identified via its molecular formula – C₁₄H₁₅N₆O₄·H₂SO₄ – and characteristic radiant properties observed in techniques such as mass spectrometry and infrared spectroscopy. Abarelix, a gonadotropin-releasing hormone (GnRH) receptor inhibitor, presents with a complex peptide sequence, typically requiring amino acid sequencing and peptide mapping for complete identification. Finally, Abiraterone Acetate, a CYP17 inhibitor utilized in prostate malignancy treatment, can be verified through its specific mass and fragmentation patterns acquired through gas chromatography-mass spectrometry (GC-MS) alongside nuclear magnetic resonance (NMR) analytical data, ensuring its precise chemical characterization.

Catalogue: Abacavir Sulfate (CAS 188062-50-2) & Related Materials

Explore a extensive listing detailing Abacavir Sulfate, identified by CAS number 188062-50-2, and a selection of related substances. Our offering includes multiple grades to satisfy precise research and manufacturing requirements. Visitors will detailed information including chemical data and available quantities options. Besides, investigate a lineup of structurally similar materials that may be helpful in the ongoing initiative. This listing is designed to aid streamlined acquiring of pure APRYMYCIN 65710-07-8 chemical ingredients.

Pharmaceutical Index: Abarelex and Abiraterone Acetate Chemical Abstract Service Numbers

For researchers and medicinal professionals seeking precise chemical identification, correct Chemical Abstract Service numbers are crucial. Specifically, abarelix, a hormone-releasing hormone modulator used in managing prostate tumors, is designated the CAS number 65572-21-8. Furthermore, abiraterone acetate, a key medication in metastatic disease, carries the Registry number 389292-17-3. Thorough recording and verification of these CAS codes are imperative to guarantee accurate molecule assessment and subsequent processes. This identifiers are publicly obtainable through different research repositories. Always consult official references for the most information.

Pharmaceutical Components: Abacavir , , Abiraterone Acetate , Registry Identifiers

The recognition of essential pharmaceutical compounds often relies on accurate chemical references. Specifically, this article quickly covers three notable cases: Abacavir, a nucleoside reverse transcriptase inhibitor; , a hormone stimulator; and Abiraterone Acetate, utilized in tumor treatment. Each substance is associated with a unique CAS number, providing a consistent method for locating information and ensuring correct reporting within the research industry. Consult the respective databases for full listings and associated data.

CAS Number Database: Information for Abacavir Sulfate, Abarelix, Abiraterone Acetate

The comprehensive Chemical Abstracts Service (CAS) number is an essential resource for researchers and manufacturing professionals alike. This section briefly outlines data pertaining to three important pharmaceutical compounds: Abacavir Sulfate, a medication used to manage HIV; Abarelix Acetate, a antagonist used in prostate cancer; and Abiraterone Acetate Salt, a effective medication applied in the treatment of metastatic advanced cancer. Finding the precise CAS number for each molecule allows for reliable identification and promotes correct research exploration. These individual identifiers are vital for compound accuracy and consistent documentation across the industry.

Employing API Chemical Data: Compound Determination with CAS Numbers

Accurate item identification is paramount in the substance industry, and Web API chemical data provides a reliable solution. Specifically, Chemical Abstracts Service numbers act as distinct labels for substance entities, permitting seamless integration with databases and systems. This kind of methodology also enhances records precision but also accelerates processes related to analysis, acquisition, and regulatory submission. Moreover, retrieving this information via an Application Programming Interface facilitates optimization and lessens the potential for operator oversight.

Report this wiki page